Despite expanded Medicare coverage racial disparities continue in colorectal cancer screening

Despite expanded Medicare coverage for colorectal cancer screening tests, lower rates still exist among blacks and Hispanics compared to other ethnic groups, according to research published in Cancer, Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.

Researchers from the University of Texas School of Public Health used data from the Surveillance Epidemiology and End Results Program (SEER), a National Cancer Institute database, to determine the prevalence of colorectal cancer screenings among Medicare beneficiaries aged 70 to 89 years with no history of any tumor. Researchers examined the data for an effect of Medicare's expansion of colorectal cancer screening; including coverage of fecal occult blood test, sigmoidoscopy and colonoscopy.

"Colorectal cancer screening increased as Medicare coverage expanded," said Aricia White, Ph.D., an epidemic service officer at the Centers for Disease Control and Prevention. "However, screening rates were still low according to recommendations."

White and colleagues analyzed data from 16 SEER regions of the United States between 1996 and 2005, and found that blacks were less likely than whites to receive colorectal cancer screening before and during Medicare coverage of fecal occult blood test and after coverage of colonoscopy. Hispanics were also less likely to receive screening after colonoscopy coverage.

Electra Paskett, Ph.D., M.P.H., professor in the college of medicine at the Ohio State University and Comprehensive Cancer Center and deputy editor of Cancer, Epidemiology, Biomarkers & Prevention, said this study, like others before it, shows that "we need to make a more concerted effort to make sure that everyone who is eligible to receive these tests gets screened."

"Interventions might need to be focused on the people who are less likely to receive the screening test," she added.

Although there are no follow-up studies planned, this is an area that needs further study.

"While screening rates increased over time, they are still lower than national recommendations," said White. "More efforts need to be made to increase colorectal cancer screening among all beneficiaries."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Many Americans unaware of alcohol's cancer risks, survey shows